4//SEC Filing
Altarac David 4
Accession 0001104659-19-060495
CIK 0001724344other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:03 PM ET
Size
5.4 KB
Accession
0001104659-19-060495
Insider Transaction Report
Form 4
Altarac David
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-11-04+120,000→ 120,000 totalExercise: $5.70Exp: 2029-11-03→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on November 4, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Entasis Therapeutics Holdings Inc.
CIK 0001724344
Entity typeother
Related Parties
1- filerCIK 0001792615
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:03 PM ET
- Size
- 5.4 KB